Syntal Capital Partners’s Eli Lilly LLY Stock Holding History

Syntal Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-953	Closed	-$512K	–	66
2023 Q3	$512K	Buy	+953	New	+$491K	0.4%	60
2022 Q4	–	Sell	-3,738	Closed	-$1.21M	–	100
2022 Q3	$1.21M	Sell	3,738 -4,693	-56%	-$1.49M	0.49%	38
2022 Q2	$2.73M	Buy	8,431 +4,285	+103%	+$1.29M	1.21%	16
2022 Q1	$1.19M	Buy	+4,146	New	+$1.07M	0.46%	59
2019 Q2	–	Sell	-9,710	Closed	-$1.26M	–	269
2019 Q1	$1.26M	Buy	+9,710	New	+$1.18M	0.57%	28
2015 Q4	–	Sell	-190	Closed	-$15K	–	112
2015 Q3	$15K	Hold	190	–	–	0.02%	125
2015 Q2	$15	Hold	190	–	–	0.01%	143
2015 Q1	$13K	Buy	+190	New	+$13.5K	0.02%	153
2014 Q4	–	Sell	-190	Closed	-$12K	–	183
2014 Q3	$12K	Hold	190	–	–	0.01%	175
2014 Q2	$11K	Sell	190 -399	-68%	-$23.8K	0.01%	195
2014 Q1	$34	Buy	+589	New	+$32.9K	0.02%	94

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Syntal Capital Partners's LLY Position: Q4 2023 in Review

Syntal Capital Partners sold out of Eli Lilly (LLY) in Q4 2023, closing a stake of 953 shares — an estimated $512K sold.

Syntal Capital Partners first reported a position in LLY in Q1 2014 and held it in 11 quarters. The position peaked at $2.73M in Q2 2022. 3,273 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

Syntal Capital Partners reported no remaining Eli Lilly position as of Q4 2023 after selling out during the quarter.
Syntal Capital Partners sold 953 Eli Lilly shares in Q4 2023, an estimated $512K.
Syntal Capital Partners first reported a position in Eli Lilly in Q1 2014 and held it in 11 quarters.
Syntal Capital Partners's Eli Lilly position peaked at $2.73M in Q2 2022.
3,273 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Syntal Capital Partners's 13F filing for Q4 2023, filed 13 Feb 2024.